Novartis CEO takes pay cut as AbbVie’s Rick Gonzalez nabs nearly 10% raise

Two CEOs are looking at noticeably different compensation packages this year when compared to last year.

Novartis CEO Vas Narasimhan, who recently took over as chair of the PhRMA board, last year brought home 8.4 million Swiss francs ($9 million), which was a 25% decrease from a year prior, when...

Click to view original post